(DOW) Dow - Overview
Stock: Polyethylene, Ethylene, Polyurethanes, Coatings, Silicones
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.25% |
| Yield on Cost 5y | 4.81% |
| Yield CAGR 5y | -6.94% |
| Payout Consistency | 93.9% |
| Payout Ratio | 700.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 45.4% |
| Relative Tail Risk | -5.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.07 |
| Alpha | -31.01 |
| Character TTM | |
|---|---|
| Beta | 1.465 |
| Beta Downside | 1.690 |
| Drawdowns 3y | |
|---|---|
| Max DD | 62.16% |
| CAGR/Max DD | -0.23 |
Description: DOW Dow January 03, 2026
Dow Inc. (NYSE:DOW) is a global materials-science company that serves packaging, infrastructure, mobility and consumer markets through three operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings. The Packaging & Specialty Plastics segment produces ethylene-based polymers and elastomers; the Industrial Intermediates & Infrastructure segment supplies polyurethanes, chlor-alkali chemicals and construction chemicals; and the Performance Materials & Coatings segment offers architectural and industrial coatings, as well as silicon-based building blocks. Dow also maintains a non-core property-and-casualty insurance and reinsurance business.
Key metrics from FY 2023 show $23.2 billion in revenue, an adjusted EBITDA margin of roughly 12 %, and capital expenditures of $1.8 billion focused on expanding its high-margin specialty polymer capacity. The company’s performance is tightly linked to feedstock (natural-gas) pricing, global construction spending, and the growth of e-commerce-driven packaging demand-each of which can swing earnings by several percentage points. Dow’s ongoing cost-reduction program targets a 5 % improvement in operating leverage by 2025, while its recent acquisition of a specialty coatings platform is expected to lift the Performance Materials segment’s contribution margin by 150 basis points.
For a deeper quantitative view, you may want to explore ValueRay’s detailed DOW financial model.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -2.62b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA -4.20 > 1.0 |
| NWC/Revenue: 22.22% < 20% (prev 14.67%; Δ 7.55% < -1%) |
| CFO/TA 0.03 > 3% & CFO 1.78b > Net Income -2.62b |
| Net Debt (16.74b) to EBITDA (1.22b): 13.72 < 3 |
| Current Ratio: 1.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (718.2m) vs 12m ago 1.86% < -2% |
| Gross Margin: 6.22% > 18% (prev 0.10%; Δ 611.4% > 0.5%) |
| Asset Turnover: 69.00% > 50% (prev 74.97%; Δ -5.97% > 0%) |
| Interest Coverage Ratio: -1.80 > 6 (EBITDA TTM 1.22b / Interest Expense TTM 897.0m) |
Altman Z'' 1.98
| A: 0.15 (Total Current Assets 18.06b - Total Current Liabilities 9.18b) / Total Assets 58.54b |
| B: 0.29 (Retained Earnings 16.78b / Total Assets 58.54b) |
| C: -0.03 (EBIT TTM -1.61b / Avg Total Assets 57.92b) |
| D: 0.22 (Book Value of Equity 9.13b / Total Liabilities 41.02b) |
| Altman-Z'' Score: 1.98 = BBB |
Beneish M -2.55
| DSRI: 1.04 (Receivables 6.64b/6.86b, Revenue 39.97b/42.96b) |
| GMI: 1.66 (GM 6.22% / 10.34%) |
| AQI: 0.95 (AQ_t 0.29 / AQ_t-1 0.30) |
| SGI: 0.93 (Revenue 39.97b / 42.96b) |
| TATA: -0.08 (NI -2.62b - CFO 1.78b) / TA 58.54b) |
| Beneish M-Score: -2.55 (Cap -4..+1) = A |
What is the price of DOW shares?
Over the past week, the price has changed by +15.35%, over one month by +24.53%, over three months by +45.15% and over the past year by -11.90%.
Is DOW a buy, sell or hold?
- StrongBuy: 4
- Buy: 0
- Hold: 16
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the DOW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.3 | -7.8% |
| Analysts Target Price | 29.3 | -7.8% |
| ValueRay Target Price | 34.7 | 9.3% |
DOW Fundamental Data Overview February 07, 2026
P/S = 0.5494
P/B = 1.4523
P/EG = 0.5389
Revenue TTM = 39.97b USD
EBIT TTM = -1.61b USD
EBITDA TTM = 1.22b USD
Long Term Debt = 17.85b USD (from longTermDebt, last quarter)
Short Term Debt = 652.0m USD (from shortTermDebt, last quarter)
Debt = 20.70b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.74b USD (from netDebt column, last quarter)
Enterprise Value = 38.84b USD (21.96b + Debt 20.70b - CCE 3.82b)
Interest Coverage Ratio = -1.80 (Ebit TTM -1.61b / Interest Expense TTM 897.0m)
EV/FCF = -14.88x (Enterprise Value 38.84b / FCF TTM -2.61b)
FCF Yield = -6.72% (FCF TTM -2.61b / Enterprise Value 38.84b)
FCF Margin = -6.53% (FCF TTM -2.61b / Revenue TTM 39.97b)
Net Margin = -6.56% (Net Income TTM -2.62b / Revenue TTM 39.97b)
Gross Margin = 6.22% ((Revenue TTM 39.97b - Cost of Revenue TTM 37.48b) / Revenue TTM)
Gross Margin QoQ = 5.79% (prev 6.91%)
Tobins Q-Ratio = 0.66 (Enterprise Value 38.84b / Total Assets 58.54b)
Interest Expense / Debt = 1.06% (Interest Expense 219.0m / Debt 20.70b)
Taxrate = 21.0% (US default 21%)
NOPAT = -1.28b (EBIT -1.61b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.97 (Total Current Assets 18.06b / Total Current Liabilities 9.18b)
Debt / Equity = 1.29 (Debt 20.70b / totalStockholderEquity, last quarter 16.01b)
Debt / EBITDA = 13.72 (Net Debt 16.74b / EBITDA 1.22b)
Debt / FCF = -6.41 (negative FCF - burning cash) (Net Debt 16.74b / FCF TTM -2.61b)
Total Stockholder Equity = 16.89b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.53% (Net Income -2.62b / Total Assets 58.54b)
RoE = -15.53% (Net Income TTM -2.62b / Total Stockholder Equity 16.89b)
RoCE = -4.65% (EBIT -1.61b / Capital Employed (Equity 16.89b + L.T.Debt 17.85b))
RoIC = -3.82% (negative operating profit) (NOPAT -1.28b / Invested Capital 33.35b)
WACC = 6.23% (E(21.96b)/V(42.65b) * Re(11.31%) + D(20.70b)/V(42.65b) * Rd(1.06%) * (1-Tc(0.21)))
Discount Rate = 11.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.03%
Fair Price DCF = unknown (Cash Flow -2.61b)
EPS Correlation: -90.29 | EPS CAGR: -56.16% | SUE: 1.06 | # QB: 1
Revenue Correlation: -89.18 | Revenue CAGR: -11.98% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.34 | Chg30d=-0.147 | Revisions Net=-4 | Analysts=13
EPS current Year (2026-12-31): EPS=-0.38 | Chg30d=-0.165 | Revisions Net=-3 | Growth EPS=+59.3% | Growth Revenue=-1.4%
EPS next Year (2027-12-31): EPS=0.64 | Chg30d=-0.087 | Revisions Net=+3 | Growth EPS=+267.6% | Growth Revenue=+3.9%